Outlook Therapeutics
OTLK
$8.50
Share price
-4.71%
Change (1 day)
626.50%
Change (1 year)
Categories
Outlook Therapeutics (OTLK) - Total assets
Total assets on the balance sheet as of December 2023 : $21.68 M
According to Outlook Therapeutics 's latest financial reports the company's total assets are $21.68 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Outlook Therapeutics - Total assets on balance sheet (from 2015 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-09-30 | $32.3 M | 13.23% |
| 2022-09-30 | $28.52 M | 25.06% |
| 2021-09-30 | $22.81 M | 15.6% |
| 2020-09-30 | $19.73 M | 15.16% |
| 2019-09-30 | $17.13 M | -23.1% |
| 2018-09-30 | $22.28 M | 7.47% |
| 2017-09-30 | $20.73 M | -18.39% |
| 2016-09-30 | $25.4 M | -27.43% |
| 2015-09-30 | $35 M | 0% |
| 2014-09-30 | $35 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $8.88 M | -59.05% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.20 B | 832.75% | 🇬🇧 UK |
 Novavax NVAX | $1.79 B | 8,189.09% | 🇺🇸 USA |
 Novocure
NVCR | $1.14 B | 5,185.36% | Jersey |